Plains GP Holdings, L.P. (NYSE:PAGP) Receives $23.55 Average PT from Analysts

Shares of Plains GP Holdings, L.P. (NYSE:PAGPGet Free Report) have been given a consensus rating of “Hold” by the thirteen analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $23.5455.

PAGP has been the topic of several recent research reports. Mizuho raised their price target on Plains GP from $25.00 to $27.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Morgan Stanley increased their target price on Plains GP from $26.00 to $28.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 18th. Citigroup increased their price objective on shares of Plains GP from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Thursday, May 14th. The Goldman Sachs Group raised Plains GP from a “sell” rating to a “neutral” rating and lifted their target price for the company from $18.00 to $24.00 in a research report on Wednesday, June 3rd. Finally, Zacks Research raised shares of Plains GP from a “strong sell” rating to a “hold” rating in a research note on Wednesday, July 22nd.

Get Our Latest Stock Report on PAGP

Institutional Trading of Plains GP

Several hedge funds and other institutional investors have recently modified their holdings of the stock. First Bancorp Inc ME bought a new position in shares of Plains GP during the second quarter worth approximately $30,000. Larson Financial Group LLC bought a new position in shares of Plains GP in the 3rd quarter valued at $46,000. North Star Investment Management Corp. acquired a new position in shares of Plains GP during the 1st quarter worth $56,000. Lazard Asset Management LLC lifted its holdings in shares of Plains GP by 36.5% in the second quarter. Lazard Asset Management LLC now owns 3,030 shares of the pipeline company’s stock worth $58,000 after acquiring an additional 811 shares during the last quarter. Finally, Continuum Advisory LLC bought a new position in Plains GP in the 2nd quarter valued at approximately $61,000. Institutional investors own 88.30% of the company’s stock.

Plains GP Price Performance

Shares of PAGP stock opened at $28.13 on Monday. The stock’s fifty day moving average is $25.33 and its 200-day moving average is $24.18. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.92 and a current ratio of 1.01. The stock has a market capitalization of $5.57 billion, a PE ratio of 53.08 and a beta of 0.46. Plains GP has a 52 week low of $16.68 and a 52 week high of $28.15.

Plains GP Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 31st were paid a $0.4175 dividend. This represents a $1.67 annualized dividend and a yield of 5.9%. The ex-dividend date was Friday, July 31st. Plains GP’s dividend payout ratio (DPR) is 59.86%.

About Plains GP

(Get Free Report)

Plains GP Holdings, L.P. (NYSE: PAGP) serves as the general partner of Plains All American Pipeline, L.P., one of North America’s leading energy infrastructure companies. Through its ownership of a 2% general partner interest and incentive distribution rights (IDRs), Plains GP Holdings participates in the governance and cash distribution structure of a diversified portfolio of crude oil and natural gas liquids gathering, transportation, storage, and terminaling assets.

The company’s primary business activities include overseeing the strategic direction and capital allocation decisions for its affiliated midstream operations.

Featured Articles

Analyst Recommendations for Plains GP (NYSE:PAGP)

Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.